School of Medicine
Showing 1-100 of 117 Results
-
Ronaldo Francisco Jr
Postdoctoral Scholar, Pathology
BioI am a geneticist focused on the application of computational and statistical methods to study genetic mechanisms of disease. My research interests include (i) genomic and precision medicine; (ii) detection and analysis of genetic variants using NGS data (WGS, WES, RNA-Seq); and (iii) transcriptome and allele-specific expression.
-
Dr. Qiwen Deng
Postdoctoral Scholar, Pathology
BioHow fibroblasts participate in the organ fibrosis and whether targeting fibroblasts is a good strategy to reverse fibrosis is still a mystery. We have identified two important immune checkpoints, CD47 and PD-L1, are highly expressed in fibroblasts and blocking CD47 and PD-L1 reversed lung fibrosis. This is a prove of concept that targeting immune regulatory pathways could be an effective therapeutic approach to treat fibrotic diseases. In addition to identifying novel targets for the treatment of fibrosis, I am also interested in the crosstalk between fibroblasts and innate immune cells in the development of fibrosis. Combined with cutting-edge NGS approaches including single cell sequencing, spatial transcriptomics and high-dimensional CyTOF technique, we have identified several potential targets and characterized immune cells landscape in lung fibrosis. In the long run, I will focus on the validation of these targets. Specifically, I will apply gain- and loss-function approaches to investigate their role in fibrosis in vitro and in vivo.
-
Jelle Folkerts
Postdoctoral Scholar, Pathology
BioDr. Folkerts received his master's degree in Drug Innovation from Utrecht University in the Netherlands, during which he spent a year at the Galli lab at Stanford on a Fulbright Scholarship. During this time, Dr. Folkerts played a key role in developing a technology platform employing functional genomics and high-resolution single-cell confocal imaging, enabling the rapid identification of degranulation regulators in primary human mast cells. Following his time at Stanford, Dr. Folkerts studied the regulatory mechanisms of human mast cell activation under the guidance of Rudi Hendriks and Marcus Maurer, earning his Ph.D. in 2022. He then returned to Stanford as a postdoctoral fellow in the Galli lab, where his current research focuses on the identification of human mast cell degranulation regulators using a whole-genome CRISPR knockout library screen, and the validation of these findings using the recently developed technology platform. It is his long-standing goal to contribute to the design and development of specific and effective therapeutic interventions for mast cell-mediated diseases.
-
Morgan Mann
Postdoctoral Scholar, Pathology
BioMorgan W. Mann, PhD, is a postdoctoral researcher at Stanford University and clinical chemistry DABCC fellow at the University of California – San Francisco (UCSF). His personal and professional interests involve the development of novel clinical assays to streamline medical diagnostics and address emerging challenges to our healthcare systems. Prior to his joint positions at Stanford and UCSF, Morgan earned his PhD in Cellular and Molecular Pathology at the University of Wisconsin – Madison, where he applied mass spectrometry-based proteomics to study innate inflammation signaling pathways and viral protein structure in the context of airway infection. He received dual bachelor’s degrees in Biochemistry and Mathematics from the University of Oklahoma.
-
Michelle M. Miranda Vélez
Postdoctoral Scholar, Pathology
BioMichelle Miranda (she/her) is a postdoctoral scholar in the Dodd Lab in the Pathology Department. Her research interest lies in bridging science and medicine by implementing core chemistry to study and improve human health.
-
Shaghayegh Navabpour
Postdoctoral Scholar, Pathology
Current Research and Scholarly InterestsMy research interests lie at the intersection of genetics and epigenetics, with a current focus on cancer and drug development. I am particularly interested in bifunctional small molecules, such as Transcriptional/Epigenetic Chemical Inducers of Proximity (TCIPs). My work now concentrates on designing, synthesizing, and testing new TCIPs that utilize various transcription factors or histone modifiers to target genes implicated in different types of cancer. Through this approach, I aim to develop innovative therapies that can more precisely and effectively combat cancer, especially to ease the treatment process for vulnerable patients, such as children and adolescents.
-
Amalia Perna
Postdoctoral Scholar, Pathology
BioDr. Perna received her education at the University of Urbino (BSc in Biological Science) and at the University of Trieste (MSc in Functional Genomics).
She obtained her Ph.D. in Neuroscience/Medical Sciences in 2021, from the University of Fribourg (Switzerland) in collaboration with the Swiss Integrative Center for Human Health (SICHH). During her doctoral studies, she investigated the molecular players involved in the neurodegenerative process, with special attention to Notch signaling modulation in the neuronal demise after kainic acid (KA)-induced excitotoxicity
With funding from the Swiss National Science Foundation (SNSF), Dr. Perna joined Prof. Thomas Montine's lab at Stanford University and extended her doctoral research work to single-cell technologies such as single-nucleus RNA-seq. In February 2022 she was appointed as a postdoctoral fellow in Montine Lab.
Dr. Perna’s research aims to elucidate the modulation of signaling pathways in the different cell types of the brain after the perturbation of its homeostasis. She is also interested in understanding the molecular mechanisms underlying neuronal regeneration/recovery after damage and in neurodegenerative diseases. -
Chenhui Qiu
Postdoctoral Scholar, Pathology
BioChenhui Qiu majored in Biomedical Engineering and received Ph.D at Zhejiang University.
Then, he was a postdoc and research associate at Department of Applied Mathematics, School of Mathematical Sciences, Zhejiang University.
Then, he was a postdoc at Department of Radiation Oncology, School of Medicine, Stanford University.
Currently, he is a postdoc at Department of Pathology, School of Medicine, Stanford University.
His research interests are medical image processing and analysis (especially in image registration & fusion, image segmentation, object detection and tracking), radiation-based neuromodulation & neuro-oncology, radiation treatment planning, intelligent computing, convex optimization, machine learning-deep learning. -
Suman Rimal
Postdoctoral Scholar, Pathology
BioResearch interests: Genetic mechanism underlying mitochondrial pathology, neurodegeneration, and muscle loss using Drosophila as a model organism.
-
Matteo Santoro Pharm.D., Ph.D.
Postdoctoral Scholar, Pathology
BioDr. Santoro joined Shamloo’s lab in March 2021 focusing his research on Parkinson’s disease, neuronal vulnerability, and identification of therapeutic markers in relation to α-synucleinopathies. Prior to his arrival at Stanford, he held a position as a clinical monitor at Syneos Health where he gained key knowledge needed to translate lab-based findings into clinical and commercial applications. Previously, Dr. Santoro held a postdoctoral position at the University of Aberdeen (Scotland, UK) working on amyloid-beta extracts from Alzheimer’s disease patients. During his postdoctoral research, Dr. Santoro designed and optimized a cost-effective and rapid assay for the measurement of toxic amyloid-beta species in human biofluids. In 2017, he obtained his Ph.D. (4-year program) at the University of Aberdeen on Parkinson’s disease (PD), immunology, and behavior. The major findings Ph.D. findings were the following: 1) the characterization of a small protein called HMGB1 as an inflammatory mediator in PD; 2) the motor and non-motor behavioral characterization of three neurotoxin based mouse models of PD, 3) the characterization of the innate immune response in PD through the toll-like receptor signaling pathways 4) evaluation of the effects of chronic systemic inflammation on both resident and infiltrating immune cells in the CNS. In 2012 Dr. Santoro attained his Pharm.D. in chemistry and pharmaceutical technology (5-year program) at the University of Calabria (Italy) during which he undertook an internship at the King’s College London (SGDP Centre) and worked for over a year on a rat model of stroke.
-
Melissa Steele-Ogus
Postdoctoral Scholar, Pathology
BioMelissa Steele-Ogus grew up in Berkeley, California. She received a BS in Environmental Sciences and BA in Molecular Biology from the University of California, Berkeley, in 2012. She earned a PhD in Biology from the University of Washington in 2021, studying the actin cytoskeleton of Giardia lamblia. In her free time, she enjoys dancing, baking, and birdwatching. She may be secretly some sort of weird bug, but probably isn't.
-
Shih-Po Su
Postdoctoral Scholar, Pathology
BioI am a Postdoctoral Research Fellow in the Department of Pathology at Stanford University.
My primary areas of expertise are Medical Image Computing and Mechanical Design.
During my doctoral studies, I focused on "3D NIR-II/SWIR fluorescence imaging for small animals in preclinical studies".
I successfully developed 3D NIR-II/SWIR fluorescence imaging using single-camera stereo vision to study the biodistribution of mice.
At present, I am working on a project related to NIR-II fluorescence imaging in surgical guidance.
Please feel free to contact me if you are interested in collaborating on research. -
Lev Tsypin
Postdoctoral Scholar, Pathology
Current Research and Scholarly InterestsI am working with Botryococcus braunii, a species of freshwater microscopic algae. This organism is unique among plants in that it secretes copious amounts of oil that is chemically analogous to petroleum. This organism may be the key to developing a cheap and sustainable alternative to fossil fuels, but we do not yet have the tools to engineer or optimize its oil production. My work aims to bridge this gap.
-
Lianna Wat
Postdoctoral Scholar, Pathology
BioLianna obtained her Ph.D. in Cell and Developmental Biology in Dr. Elizabeth Rideout’s lab at the University of British Columbia in 2021 where she studied the sex-specific regulation of fat metabolism using Drosophila as a model system. Lianna is bringing her expertise on sex differences and fat metabolism to the Svensson lab where she is interested in understanding in discovering secreted metabolic effectors that regulate male-female differences in energy metabolism and the development of metabolic disease
